A study of 6522 patients found that 24 (0.4%) had experienced adverse reactions, the most frequent being anorexia, nausea, vomiting, and rash [29]
Between February and March 2026, the FDA issued warning letters to more than 30 telehealth companies for misleading marketing of compounded GLP-1 products
The most cited single result is from Yun and colleagues in 2018, who showed that NLY01, a long-acting PEGylated GLP-1R agonist, blocked the microglia-driven conversion of resting astrocytes into the neurotoxic A1 phenotype in mouse models, a process implicated in neuronal death in both Parkinsons and Alzheimers disease [4]
At Intra-V, we're committed to helping you heal faster, move better, and feel your bestnaturally.
The relatively superficial nature of these tendons may allow for more effective local peptide concentration when using nearby subcutaneous injections
It depends on current availability and pricing for compounded formulations, which fluctuate based on FDA enforcement actions and shortage designations